Research ArticleRheumatoid Arthritis
Open Access
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Mark C. Genovese, César Pacheco-Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Mauro Keiserman, Robert M. Valente, Peter Nash, J. Abraham Simon-Campos, Jane Box, Clarence W. Legerton III, Evgeny Nasonov, Patrick Durez, Ayanbola Elegbe, Robert Wong, Xiaohui Li, Subhashis Banerjee and Rieke Alten
The Journal of Rheumatology August 2018, 45 (8) 1085-1092; DOI: https://doi.org/10.3899/jrheum.170344
Mark C. Genovese
From Stanford University, Palo Alto, California; Arthritis Center of Nebraska, Lincoln, Nebraska; Box Arthritis and Rheumatology of the Carolinas, Charlotte, North Carolina; Low Country Rheumatology, Charleston, South Carolina; Bristol-Myers Squibb, Princeton, New Jersey,
USA; Universidad Autónoma de Chihuahua, Chihuahua; Unidad Reumatológica Las Américas S.C.P., Mérida; Köhler & Milstein Research, Mérida,
Mexico; Instituto De Ginecología Y Reproducción, Lima,
Peru; Organización Médica de Investigación, Buenos Aires,
Argentina; Pontifical Catholic University, Porto Alegre,
Brazil; University of Queensland, Brisbane,
Australia; Russian Academy of Medical Sciences, Moscow,
Russia; Cliniques Universitaires Saint-Luc; Université Catholique de Louvain, Brussels,
Belgium; Schlosspark-Klinik University Medicine, Berlin,
Germany.
César Pacheco-Tena
Arturo Covarrubias
Gustavo Leon
Eduardo Mysler
Mauro Keiserman
Robert M. Valente
Peter Nash
J. Abraham Simon-Campos
Jane Box
Clarence W. Legerton III
Evgeny Nasonov
Patrick Durez
Ayanbola Elegbe
Robert Wong
Xiaohui Li
Subhashis Banerjee
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 45, Issue 8
1 Aug 2018
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Mark C. Genovese, César Pacheco-Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Mauro Keiserman, Robert M. Valente, Peter Nash, J. Abraham Simon-Campos, Jane Box, Clarence W. Legerton, Evgeny Nasonov, Patrick Durez, Ayanbola Elegbe, Robert Wong, Xiaohui Li, Subhashis Banerjee, Rieke Alten
The Journal of Rheumatology Aug 2018, 45 (8) 1085-1092; DOI: 10.3899/jrheum.170344
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial
Mark C. Genovese, César Pacheco-Tena, Arturo Covarrubias, Gustavo Leon, Eduardo Mysler, Mauro Keiserman, Robert M. Valente, Peter Nash, J. Abraham Simon-Campos, Jane Box, Clarence W. Legerton, Evgeny Nasonov, Patrick Durez, Ayanbola Elegbe, Robert Wong, Xiaohui Li, Subhashis Banerjee, Rieke Alten
The Journal of Rheumatology Aug 2018, 45 (8) 1085-1092; DOI: 10.3899/jrheum.170344